BridgeBio Pharma, Inc. (BBIO): Total Assets
$936.02M
As of 2025-12-31
$1.22B
As of 2026-06-30
+14.5%
3-year compound annual growth
+5.9%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $936.02M | +1.8% | 2026-02-24, Balance as of period end |
| 2024-12-31 | $919.34M | +68.3% | 2026-02-24, Balance as of period end |
| 2023-12-31 | $546.38M | -12.3% | 2025-02-20, Balance as of period end |
| 2022-12-31 | $623.04M | -38.5% | 2024-02-22, Balance as of period end |
| 2021-12-31 | $1.01B | +43.9% | 2023-02-23, Balance as of period end |
| 2020-12-31 | $703.59M | +11.4% | 2022-02-25, Balance as of period end |
| 2019-12-31 | $631.68M | +35.9% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $464.94M | n/a | 2020-03-03, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | $936.02M | +1.8% |
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | $605.19M | +1.9% |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | $842.81M | +25.7% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $261.15M | +8.4% |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $1.75B | +37.6% |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | $1.17B | -1.1% |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $598.73M | +20.3% |
| Insmed Inc (INSM) | 2025-12-31 | $2.26B | +11.8% |
| Opko Health, Inc. (OPK) | 2025-12-31 | $1.93B | -12.2% |
Compare BBIO, TVTX, MIRM, NATR side by side · Screen every company in Pharmaceutical Preparations ↗